Microsynth will exclusively market and sell Sloning's gene synthesis service (Slonomics™) and the product family of mutant libraries (Slonomax™) in Switzerland.
“We are very pleased that Microsynth will join our global network of qualified distributors. With its strong technological expertise, market position and service philosophy Microsynth is the ideal partner for Sloning to develop the Swiss market,” stated Thomas Matthes, the company CBO.
Dr. Tobias Schmidheini, founder and CEO of Microsynth said, “Sloning´s products and services perfectly complement our portfolio. It’s a strategic development for our organization. We are looking forward to offering Sloning´s products to our customer base.”